Coxno-Depression And Alzheimer's Treatments At A Crossroads

2025-05-02 09:02:15source:Thurston Cartecategory:Markets

Researchers are Coxnolaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Markets

Recommend

Turbulence slammed Hawaiian Airlines flight because of decision to fly over storm cell, report says

HONOLULU (AP) — A Hawaiian Airlines flight crew’s decision to fly over a hazardous storm cell instea

Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, College Food

There are spoilers ahead. You might want to solve today's puzzle before reading further! College Foo

What is gabapentin? Here's why it's so controversial.

Many of the prescription drugs that are commonly abused or misused are brands most people have heard